Supplemental oxygen helps some people with COPD, but not all. The benefit depends almost entirely on how low your blood oxygen levels have dropped. For people with severely low oxygen (a resting blood oxygen saturation of 88% or below), long-term oxygen therapy is one of the few treatments proven to extend life. For those with only mildly reduced levels, the evidence shows little to no benefit.
Who Benefits Most From Oxygen Therapy
The clearest evidence for oxygen therapy applies to people with COPD who have severe resting hypoxemia, meaning their blood oxygen stays persistently low even when sitting still. The standard threshold is a resting oxygen saturation of 88% or below on a pulse oximeter. People who have slightly higher readings (89%) but also show signs of strain on the heart, such as leg swelling or elevated red blood cell counts, also qualify.
For people in this range, using supplemental oxygen for at least 15 hours a day significantly reduces the risk of dying. Two landmark trials from the late 1970s established this. In the British Medical Research Council trial, 67% of patients who received no oxygen died within three years compared to 45% of those on oxygen. The U.S. Nocturnal Oxygen Therapy Trial found that using oxygen nearly around the clock (averaging 18 hours per day) cut the two-year mortality rate to 27%, compared to 41% for those who only used it at night. More hours of daily use means greater benefit.
People with moderate resting hypoxemia, roughly a saturation of 89 to 93%, are in a gray zone. The American Thoracic Society recommends against prescribing long-term oxygen for this group, based on trials that found no survival advantage or slowing of disease progression at these levels.
How Oxygen Protects the Body
When oxygen levels stay low for weeks or months, the blood vessels in the lungs start to constrict. This raises the pressure inside the pulmonary arteries, forcing the right side of the heart to work harder. Over time, that extra strain can lead to right-sided heart failure, a serious complication of advanced COPD. Supplemental oxygen relaxes those constricted vessels, producing small but meaningful drops in pulmonary artery pressure (typically 3 to 5 mmHg). Even when it doesn’t fully reverse the elevated pressure, oxygen slows the progression, buying the heart more time.
There are also early signals that correcting low oxygen improves brain function. Chronic hypoxemia affects concentration, memory, and mood. Studies of patients starting long-term oxygen therapy have shown trends toward better cognitive performance and improved blood flow to the brain after about three months, consistent with the idea that the brain suffers when it’s chronically starved of oxygen and recovers, at least partially, once levels are restored.
Oxygen During Exercise
Many people with COPD have acceptable oxygen levels at rest but desaturate during physical activity. Portable oxygen can make a measurable difference for this group. In a randomized crossover trial of 108 patients, those who used supplemental oxygen during a six-minute walk test covered an average of 27 meters farther than when walking on room air. The improvement was most pronounced in people whose oxygen levels actually dropped during exertion: about 42 to 47% of those patients gained at least 30 meters, the threshold considered clinically meaningful.
People whose oxygen stayed normal during exercise saw no significant benefit from carrying a portable tank. This is an important distinction. Ambulatory oxygen is most useful when there’s a documented drop in saturation during activity, not just a feeling of breathlessness.
Why Oxygen at Night Alone Isn’t Enough
Some people with COPD dip below normal oxygen levels only during sleep while remaining fine during the day. It seems logical that overnight oxygen would help, but the evidence says otherwise. A study published in The New England Journal of Medicine found that nocturnal oxygen therapy for patients with isolated nighttime desaturation did not improve survival or delay the need for full-time oxygen. At three years, outcomes were nearly identical: 39% of the oxygen group and 42% of the placebo group had either progressed to needing daytime oxygen or died. Hospitalization and exacerbation rates were also no different. Based on this, there’s no clinical reason to routinely screen for or treat nighttime-only desaturation.
The Risk of Too Much Oxygen
Oxygen isn’t harmless in COPD. Giving too much can cause carbon dioxide to build up in the blood, a condition called oxygen-induced hypercapnia. For decades, the standard explanation was that people with severe COPD rely on low oxygen as their main signal to breathe, so raising oxygen removes that signal and they stop breathing adequately. The reality is more complicated. While there is a small initial dip in breathing effort, it recovers within about 15 minutes, and studies show no strong correlation between that brief reduction and the rise in carbon dioxide.
The bigger culprit is a change in blood flow within the lungs. In healthy lungs, blood vessels automatically divert flow away from poorly ventilated areas toward regions that are getting fresh air. High oxygen concentrations override this mechanism, sending blood to parts of the lung that can’t properly exchange gases. This increases “dead space” ventilation, where blood passes through the lungs without effectively offloading carbon dioxide. A secondary factor, called the Haldane effect, means that oxygen-rich blood physically carries less carbon dioxide, releasing it into the bloodstream instead.
This is why the recommended target oxygen saturation for COPD patients is around 88 to 92%, not the 95% or higher that’s normal for healthy people. The goal is to relieve dangerous hypoxemia without overcorrecting.
Equipment and Delivery Options
Most people on long-term oxygen use a nasal cannula, a lightweight tube with two small prongs that sit just inside the nostrils. Standard flow rates run from 1 to 5 liters per minute, adjusted to keep saturation in the target range. Common complaints include nasal dryness, a dry mouth, and occasional nosebleeds, though these are generally manageable with humidifiers or water-based nasal gels.
For home use, stationary oxygen concentrators pull oxygen from room air and weigh about 10 kilograms (22 pounds). They plug into a wall outlet and provide a continuous supply without needing refills. Some newer compact models weigh as little as 4.5 kilograms and support lower flow rates up to 2 liters per minute.
For leaving the house, three main options exist:
- Portable oxygen concentrators run on rechargeable lithium-ion batteries, with some models lasting up to 12 hours on a single charge. They’re the most convenient for daily errands and travel, though most deliver oxygen in pulses rather than continuous flow.
- Compressed gas cylinders are simple and reliable. A small portable cylinder weighing about 3 kilograms holds roughly 430 liters of oxygen, enough for a few hours depending on your flow rate. The downside is they run out and need to be replaced.
- Liquid oxygen canisters are the lightest option at around 3.5 kilograms when full and can deliver high flow rates up to 15 liters per minute. Portable canisters last 8 to 10 hours, and they refill from a base unit at home that holds an 11-day supply.
The right setup depends on how many hours a day you need oxygen, your prescribed flow rate, and how active you are outside the home. Many people end up with a stationary concentrator for home and a portable system for outings.